Objective: Predicted postoperative forced expiratory volume in 1 s (ppoFEV1) is estimated in lung cancer patients before pulmonary resection, as well as the clinical stage. This study aims to evaluate ppoFEV1 and ppo-vital capacity (ppoVC) on postoperative day 7 (POD7) and to compare the results following video-assisted thoracic surgery (VATS) and open thoracotomy procedures. Methods: Of the 155 patients who underwent pulmonary resection, 70 had VATS; 30 had muscle-sparing thoracotomy (anterior limiting thoracotomy (AL)); and 55 had postero-lateral thoracotomy (PL). VC and FEV1 were measured on POD7 and compared with the VC and FEV1 before surgery using analysis of covariance (ANCOVA). The ratio of the actual-and the ppoVC and FEV1 was evaluated to identify factors associated with variations in postoperative residual VC/FEV1. Results: There were significant differences by analysis of covariance (ANCOVA) in the VC/FEV1 among the three surgical approaches. In the VATS group, the VC ratio and the FEV1 ratio were 96.5% and 94.7%, respectively; they were significantly higher in the VATS group than in the thoracotomy group (AL: 90.4% and 90.1%, respectively; PL: 87.4% and 87.6%, respectively). Non-chronic obstructive pulmonary disease (COPD) and upper lobectomy were also associated with a low VC ratio and FEV1 ratio. Conclusion: Predicted postoperative pulmonary function might be overestimated in COPD patients or in those undergoing VATS or lower lobectomy. #
Introduction
Estimation of predicted postoperative forced expiratory volumes in 1 s (ppoFEV1) is a frequently used criterion to define functional operability in patients undergoing lung resection [1] , since a low ppoFEV1 alone or in combination with other variables [2] correlates with postoperative morbidity and mortality. The surgical procedure was selected on the basis of the Institutional Criteria for the Objective Determination of Pulmonary Resection Procedures using a combination of preoperative cardiopulmonary function tests (FEV1 for the intact side !800 ml m À2 , ppoFEV1 !40% on spirometry). We also regard that more than 40% ppoFEV1 is required as a functional operability; however, ppoFEV1 (or predicted postoperative vital capacity (ppoVC)) is not a good predictor in some individuals; some patients with low pulmonary function do well postoperatively, while some patients whose ppoFEV1 was thought to be adequate are discharged on home oxygenation therapy. It has been reported that chronic obstructive pulmonary disease (COPD) patients with lower FEV1 values might have less pulmonary function loss after lobectomy [3, 4] .
The present study focussed on the association between early complications and pulmonary function; thus, pulmonary function test was investigated on postoperative day 7 (POD7). Furthermore, the present study also assessed how the surgical approach (video-assisted thoracic surgery (VATS), muscle-sparing thoracotomy or classical thoracotomy) affected early postoperative respiratory function and identified the variables that were associated with postoperative pulmonary function. Pulmonary function tests were performed before surgery and on POD7. Patients who had prolonged pulmonary leakage or drainage and those who were unable to perform the test due to any complications were excluded. Calculations of the ppoVC and the ppoFEV1 were based on the number of nonobstructed pulmonary subsegments (total, 42) to be resected, which method has been described by Nakahara et al. [5] . The ratio of the postoperative FEV1 to the ppoFEV1 (FEV1 ratio) was calculated for each patient, according to the formula: FEV1 ratio = (actual postoperative FEV1 Â 100)/ ppoFEV1. The VC ratio was calculated similarly.
Materials and methods

Patients' characteristics and clinical findings
VATS lobectomy involves endoscopic techniques with direct vision through a non-rib-spreading mini-thoracotomy (4-to 6-cm incision). The open thoracotomies were divided into two groups: the anterior limiting thoracotomy (AL) group, in which antero-lateral, antero-axillary thoracotomy or vertical incisional muscle-sparing thoracotomy was performed using an 8-to 13-cm incision, followed by dividing or partially resecting the anterior serratus muscle and preserving the latissimus dorsi muscle; and the posterolateral thoracotomy (PL) group, in which the thoracotomy was performed using a 15-cm incision, followed by dissection of the latissimus dorsi muscle and a rib. After thoracotomy, a videoscope was usually used to remove adhesions and for training purposes, and an autosuturing device or drainage tube was inserted through this porthole. In total, 70 patients had VATS, 30 patients had AL and 55 had PL. All patients were offered the same analgesic regimens by epidural catheter for postoperative pain control. The surgical approach, VATS or thoracotomy, was decided based on tumour size; most PLs were performed during 2001-2004, and most ALs were performed during 2005-2007, though the choice of some procedures was made by the surgeon.
There were 100 men and 55 women, with a median age at surgery of 68 (range, 32-83) years. The procedures included lobectomy in 143 patients, bilobectomy in eight patients and segmentectomy (anatomical resection) in the remaining four patients; left upper lobectomy (LUL), 27; left lower lobectomy (LLL), 26; right upper lobectomy (RUL), 47; right middle lobectomy (RML), 15; right lower lobectomy (RLL), 28; right upper and middle lobectomy (RUML), five and right middle and lower lobectomy (RMLL),three. COPD was diagnosed in 27 patients (17%) (FEV1.0 <70%) based on the Global initiative on Obstructive Lung Disease guidelines (GOLD standard).
Of the 122 patients whose clinical characteristics were available, there were 115 patients with primary lung cancer. Seventy-two patients were former/current smokers, with a median Brinkman index (BI, number of cigarettes per day times years) of 840; the remaining had never been smokers. Seventy-eight had adenocarcinomas, 24 had squamous cell carcinomas, eight had large-cell or neuroendocrine carcinomas, two had carcinoid, two had small-cell carcinomas and the remainder had mucoepidermoid carcinoma. Forty-eight patients had stage IA, 31 had stage IB, four had stage IIA, 10 had stage IIB, 16 had stage IIIA, five had stage IIIB and one had stage IV at the time of surgery.
Statistical analyses
Associations between surgical approach and clinical findings were assessed using the chi-square test or Fisher's exact test. The analyses compared changes from predicted pulmonary function before surgery to measured pulmonary function after surgery and between groups by surgical approach using analysis of covariance (ANCOVA) procedures in which the postsurgical value or gap (difference between predicted postoperative value and postoperative value) was the dependent variable, the predicted postoperative value was the covariate and surgical approach was the group variable. The unpaired t-test or the Mann-Whitney U test (or Kruskal-Wallis test) was used to assess the associations between quantitative variables. For all analyses, p < 0.05 was considered to be statistically significant. StatView software (version 5.5, Chicago, IL, USA) was used for all calculations.
Results
Association between surgical approach and clinical findings
Patients' characteristics are summarised in Table 1 . Seventy-three of 100 men underwent surgery via thoracotomy (47, PL; 26, AL; and 27, VATS), and 28 of 55 women underwent VATS (28, VATS; 23, PL and 4, AL) ( p = 0.0021, chi square test). Many female patients, those with stage IA and/ or adenocarcinomas, tended to be scheduled VATS. Upper lobectomy was also preferred to VATS or AL because of anatomical relevance.
Blood loss (suction and swab) was significantly different among the surgical procedures. It was less in VATS than in thoracotomy (155 AE 157 g for VATS, 260 AE 237 g for AL and 362 AE 208 g for PL). Operation time was also shorter for VATS than for thoracotomy (251 AE 56 min for VATS, 275 AE 57 min for AL and 278 AE 55 min for PL).
Postoperative hospital stay ranged from 4 to 28 (median, 10) days. Hospital stay was significantly shorter after VATS 
Association between surgical approach and pulmonary function
Results of pulmonary function test before and after pulmonary resection are showed in Fig. 1 and Table 2 .
The ppoVC and measured VC on POD7 were: 2.45 l and 2.11 l for PL; 2.87 l and 2.63 l for AL; and 2.42 l and 2.29 l for VATS. The gap between ppoVC and the measured VC was À0.34 l for PL, À0.24 l for AL and À0.13 l for VATS; the difference between PL and VATS was statistically significant on ANCOVA.
Similarly, ppoFEV1 and measured FEV1 on POD7 were: 1.80 l and 1.53 l for PL; 2.12 l and 1.87 l for AL; and 1.80 l and 1.68 l for VATS. The gap between ppoFEV1 and the measured FEV1 was À0.27 l for PL, À0.26 l for AL and À0.13 l for VATS; the difference between PL and VATS was statistically significant on ANCOVA.
Although no selection was performed about surgical approach, almost patients operated by AL were men and thus pulmonary functioning was relatively high compared with the other groups. Therefore, in this group, the results of the t-test for ppoVC and ppoFEV1 were significant, as well as for postoperative VC and FEV1, even on ANCOVA. Although the gap was less in the VATS group, the difference between the PL group and the AL group was not statistically significant.
Which factor is responsible for low respiratory volume after surgery?
Although the gaps for VC and FEV1 between ppo-and measured volume after operation were revealed to be significant, this was not considered to be due to individual pulmonary volume difference (personal equation) or surgically removed volume (upper or lower lobectomy). Therefore, the VC ratio (proportion of VC on POD7 to predicted postoperative VC) or the FEV1 ratio was compared. The VC ratio was 87.4 AE 19.4% in patients who underwent pulmonary resection via PL, 93.0 AE 13.1% in patients who underwent pulmonary resection via AL and 96.5 AE 21.3% in patients who underwent VATS; the difference between PL and VATS was statistically significant ( p = 0.0139, unpaired t-test). There was also significant difference between the thoracotomy group and the VATS group ( p = 0.0225, the VC ratio of AL + PL, 89.1 AE 17.9%).
Similarly, the FEV1 ratio (proportion of FEV1 on POD7 to predicted postoperative FEV1) was 87.6 AE 21.2% in the PL group, 90.1 AE 32.3% in the AL group and 94.7 AE 23.0% in the VATS group. There was no significant difference among the three procedures, although the difference between PL and VATS had borderline significance ( p = 0.0739).
The VC ratio was significantly higher in older (>68 years) patients than in young patients (95.2 AE 23.1% for older patients, 87.0 AE 17.0% for young patients, p = 0.0132), though there was no difference in the FEV1 ratio (FEV1 92.7 AE 24.0% for older patients, 88.4 AE 24.9% for young patients, p = 0.26). No differences were seen for gender, smoking history, stage, blood loss or operation time.
Both the VC and FEV1 ratios were significantly lower after left upper lobectomy or right upper lobectomy than after lower lobectomy ( Table 3) .
The FEV1 ratio, but not the VC ratio, was significantly higher in COPD patients than in non-COPD patients (VC ratio: 
Discussion
Although the VATS approach is less invasive than a PL, its advantages over a limited or muscle-sparing thoracotomy for lung cancer surgery have been a matter of controversy [6, 7] . Recently, several advantages of VATS lobectomy have been demonstrated with respect to postoperative clinical findings and prognosis [8, 9] . In the present study, significant differences among the three surgical approaches were seen for blood loss, operation time, drainage period (data not shown) and hospital stay. One of the reasons for the difference in operation time might be that VATS was performed by an expert surgeon, while thoracotomy and lobectomy were usually performed by residents. Moreover, difficult cases or advanced stage cases did not undergo VATS. Hospital stay in Japan has recently become relatively short, and muscle-sparing thoracotomy (AL) has been used instead of classical thoracotomy (PL), which may have decreased the length of the hospital stay. Although there were obvious differences in postoperative recovery and pulmonary function between classical thoracotomy and VATS, mini-thoracotomy, including muscle-preserving thoracotomy, has been proven to be inferior to VATS, though the definition of VATS and the difference between VATS and mini-thoracotomy have not been clarified.
A review of the literature suggested that an FEV1 > 2 l was a safe lower limit for pneumonectomy and that >1.5 l was safe for a lobectomy [1] . Olsen et al. suggested a threshold ppoFEV1 of 0.8 l as the lower limit for surgical resection [10] . Pate et al. found that patients with a mean ppoFEV1 of 0.7 l tolerated thoracotomy for lung cancer resection [11] . Nakahara et al. reported that 10 patients with ppoFEV1 < 30% needed mechanical ventilation or a tracheostomy or died postoperatively [5] . Wahi et al. found a perioperative mortality rate of 16% in patients with a %ppoFEV1 of < 41%, compared with 3% for those with better predicted lung function [12] . Taken together, FEV1 is important to evaluate in pulmonary resection candidates, even though some cases had disappointing results based on the predicted respiratory value.
Kushibe et al. observed daily changes for up to 6 days after surgery. The FEV1 ratio recovered from 71.2% on the day after surgery to 92.8% 6 days after surgery [13] . It has been reported that VC recovered the most within 2 weeks to 1 *Gap = predicted postoperative value -measured value on POD7, % = measured/predicted, y significant by ANCOVA, # significant by unpaired t-test month after surgery, and FEV1 recovered 1-3 months after surgery [14, 15] . The observed VC and FEV1 increased to 237 ml m À2 and 137 ml m À2 , respectively, from 2 weeks to 3 months after surgery. The ppoVC or ppoFEV1 is assumed to reflect the postoperative stable phase, and the measured VC or FEV1 on POD7 differed from ppoVC/FEV1. Pulmonary function testing in the present study was done during the early phase. Thus, after more than 3 months, better outcomes would be expected, the differences between measured and predicted values (ppoVC/FEV1) would decrease and the differences between the surgical approaches may disappear.
Recently, pulmonary function has been reported to remain unchanged or even improve after lobectomy in COPD patients [3, 4, 16] . In the present study, non-COPD and upper lobectomy were shown to be prognostic factors for low pulmonary function after operation. Two possibilities may explain this. After upper lobectomy, the middle or lower lobe is raised within the space previously occupied by the upper lobe, causing the bronchus and/or trachea to bend and curve, creating a new airway that might influence the expiratory volume in the early phase. Conversely, the pulmonary volume of the upper lobe may be more than the estimated volume based on the anatomical segments. Brunelli et al. reported that 27% of patients with COPD had improved FEV1 at 3 months compared with preoperative values [17] . They also showed that FEV1 decreased from the preoperative value to 3 months after lung resection through a muscle-sparing lateral thoracotomy (from 86.7% to 73.8% in the RUL group, 89.5% to 74.3% in the LUL group, 96.6% to 82.6% in the RLL group and 86.2% to 76.1% in the LLL group). Sekine et al. also reported that postoperative ventilatory function in COPD patients who had lower or middle/lower lobectomies was better preserved than had been predicted [16] .
Varela et al. reported that preoperative FEV1, the postoperative pain score and epidural analgesia were independently and reliably associated with the postoperative FEV1 ratio [18] . Early postoperative recovery may be attributable to healing from surgical injury to the chest wall and the resulting alleviation of pain. Pain seems to be relative to the wound size and caused by injury to intercostal nerves [19] ; therefore, VATS and non-ribspreading thoracotomy have been considered to be advantageous for postoperative pulmonary function. Nomori et al. reported that pain scores between 1 week and 6 months after surgery were significantly lower after anterior limiting thoracotomy (ALT) than after PL [20] , and that VATS resulted in a further lowering of the pain score for 1 week following surgery [21] . However, no significant difference in pulmonary function between after ALT and after VATS has been found [6, 21] . In the present study, VC and FEV1 were higher in older (>68 years) patients than in young patients, perhaps because older patients tend to tolerate pain relatively better [22] .
In conclusion, VATS lobectomy appears to be superior to thoracotomy-lobectomy with respect to clinical findings such as operation time, blood loss and length of hospital stay. With respect to respiratory function on POD7, upper lobectomy, non-COPD and thoracotomy were negative factors on multivariate analysis. The present study focussed on earlier postoperative functional assessment and was limited to cases that had no complications. Although the actual values of patients with any complications are difficult to evaluate, the factors identified may serve as predictive markers for safe surgery.
